Navigation Links
Lilly Declares Second-Quarter Dividend
Date:4/21/2008

INDIANAPOLIS, April 21 /PRNewswire-FirstCall/ -- The board of directors of Eli Lilly and Company (NYSE: LLY) today declared a dividend for the second quarter of 2008 of $0.47 a share on outstanding common stock. This is the same dividend as was paid in the first quarter and maintains the annual indicated dividend rate for 2008 of $1.88 per share.

The dividend is payable June 10, 2008, to shareholders of record at the close of business on May 15, 2008.

Lilly, a leading innovation-driven corporation, is developing a growing portfolio of first-in-class and best-in-class pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Ind., Lilly provides answers - through medicines and information - for some of the world's most urgent medical needs. Additional information about Lilly is available at http://www.lilly.com . F-LLY

(Logo: http://www.newscom.com/cgi-bin/prnh/20031219/LLYLOGO )


'/>"/>
SOURCE Eli Lilly and Company
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Lilly to Streamline Indianapolis Manufacturing and Engineering Operations
2. Lilly Adjusts Time of Conference Call for First Quarter 2008 Financial Results Announcement
3. Lilly Sets Date and Conference Call for First Quarter 2008 Financial Results Announcement
4. State of Alaska and Eli Lilly and Company Reach Agreement to Settle Zyprexa Lawsuit
5. Statement from Eli Lilly and Company: Response to Todays New York Times Article, Lilly E-Mail Discussed Off-Label Drug Use
6. Lilly Grants $4.4 Million to the WHO for MDR-TB Program Expansion
7. Newly Labeled Therapies for Neuropathic Pain, Including Drugs From Pfizer and Eli Lilly, Will Drive Growth in the Chronic Pain Drug Market
8. Mental Health Parity Laudable, But House Legislation Would Put Medicaid Patients at Risk, Lilly Says
9. FDA Issues Not-Approvable Letter for Lillys Zyprexa(R) Long-Acting Injection (LAI) for Schizophrenia Treatment
10. Lilly and Partners In Health, Brigham and Womens Hospital Team Up to Fight MDR-TB in Former Soviet Republics
11. Michael L. Eskew Elected to Lilly Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/22/2017)... Los Angeles, California (PRWEB) , ... March 22, 2017 , ... ... has signed British boxing champ Ashley Theophane as a new Brand Ambassador. Theophane, who ... the British light welterweight title in 2011. He has racked up an impressive number ...
(Date:3/22/2017)... ... March 22, 2017 , ... ... that its digital marketing solutions have enabled Children’s Hospital of The King’s Daughters ... , Recognizing the value of a digital marketing approach, the 206-bed pediatric ...
(Date:3/22/2017)... ... March 22, 2017 , ... The Burke Medical Research Institute ... advances in basic neuroscience at the BMRI labs into new and improved treatments ... movement, vision, and cognition impaired by stroke, traumatic brain injury, cerebral palsy, and ...
(Date:3/22/2017)... ... March 22, 2017 , ... The Vanderbeck Agency, a ... greater Nassau County region, is embarking on a combined charity effort with the Great ... For the last 25 years, the Great Neck Breast Cancer Coalition has worked to ...
(Date:3/22/2017)... (PRWEB) , ... March 22, 2017 , ... Chris Humphrey ... to families and business professionals throughout the coastal plains region, is initiating a charity ... overcome cancer. , Dillyn was first diagnosed with leukemia on a Friday evening in ...
Breaking Medicine News(10 mins):
(Date:3/22/2017)... , 22. März 2017   VWR ... weltweit tätige Anbieter von Produkten und Dienstleistungen ... Erwerb von EPL Archives Inc. bekannt, eines ... Kunden im kompletten Zyklus regulierter Forschung, Entwicklung ... Proben, Speicherung von Dokumenten und Zusatzdienstleistungen zur ...
(Date:3/22/2017)... March 22, 2017  Applied BioMath ( www.appliedbiomath.com ... drug research and development, today announced the latest ... Day 2017 is a day full of presentations, ... pharmacology (QSP) community. The focus is to learn ... and accelerating drug research and development. ...
(Date:3/22/2017)... March 22, 2017 National Medical Products ... received an Innovative Technology contract from Vizient, ... in the country. The contract was based on ... with expertise in this category who serve on ... Technology contracts for technologies that demonstrate an ability ...
Breaking Medicine Technology: